Michelle L. Basil is CLO & VP at HAEMONETICS CORP (HAE). They have made 23 open-market trades across 1 company since 2018, most recently 2026-05-15.
CIK 0001699629
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 23 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| HAE | 68,829 | $8.1M |
Shares reported on the most recent Form 4, priced at the 2026-05-19 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HAE | SELL · 10b5-1 | 2024-05-29 | 2024-05-29 | $88.08 | $2.3M | -1.9% | -5.5% | -12.4% |
| HAE | SELL · 10b5-1 | 2024-05-17 | 2024-05-21 | $95.06 | $407K | -3.1% | -2.6% | -14.7% |
| HAE | SELL · 10b5-1 | 2024-05-16 | 2024-05-17 | $96.14 | $189K | -11.0% | -10.0% | -22.2% |
| HAE | SELL | 2022-10-24 | 2022-10-26 | $80.39 | $14K | +1.8% | +1.8% | +10.4% |
| HAE | SELL | 2022-09-19 | 2022-09-21 | $78.36 | $1.8M | -0.1% | +5.4% | +3.3% |
| HAE | SELL | 2022-09-15 | 2022-09-19 | $77.89 | $5.3M | -4.5% | +1.9% | +3.4% |
| HAE | SELL | 2022-06-13 | 2022-06-15 | $62.60 | $17K | +5.8% | +5.9% | +28.2% |
| HAE | SELL | 2022-05-19 | 2022-05-23 | $59.10 | $385K | +6.2% | +0.3% | +25.8% |
| HAE | SELL | 2022-05-16 | 2022-05-18 | $56.10 | $11K | +7.5% | +3.3% | +29.7% |
| HAE | SELL | 2021-10-25 | 2021-10-27 | $71.93 | $9K | +4.3% | -23.9% | -27.8% |
| HAE | SELL | 2021-06-14 | 2021-06-16 | $59.87 | $12K | +13.8% | +0.9% | +14.0% |
| HAE | SELL | 2021-06-07 | 2021-06-09 | $55.09 | $24K | +8.8% | +8.9% | +10.7% |
| HAE | SELL | 2021-05-19 | 2021-05-20 | $55.19 | $12K | -1.9% | +11.3% | +2.9% |
| HAE | SELL | 2021-05-17 | 2021-05-18 | $55.97 | $11K | +1.7% | +12.7% | +5.9% |
| HAE | SELL | 2021-03-08 | 2021-03-10 | $120.07 | $46K | -3.2% | -2.1% | -51.9% |
| HAE | SELL | 2020-10-23 | 2020-10-26 | $106.58 | $19K | -7.4% | +6.1% | +15.9% |
| HAE | SELL | 2020-06-12 | 2020-06-16 | $89.49 | $4.2M | -3.8% | +1.6% | -1.7% |
| HAE | SELL | 2020-06-08 | 2020-06-10 | $97.03 | $133K | -9.5% | -6.1% | -2.8% |
| HAE | SELL | 2020-05-15 | 2020-05-19 | $100.44 | $20K | +5.8% | -17.4% | -17.7% |
| HAE | SELL | 2020-03-09 | 2020-03-10 | $98.00 | $39K | -20.0% | -1.4% | -5.3% |
| HAE | SELL | 2019-10-08 | 2019-10-10 | $123.22 | $4.2M | -3.0% | -6.7% | -10.0% |
| HAE | SELL | 2019-06-12 | 2019-06-13 | $109.37 | $25K | +4.5% | +10.6% | +10.5% |
| HAE | SELL | 2019-06-06 | 2019-06-10 | $103.42 | $2.1M | +8.7% | +11.8% | +11.8% |
| HAE | SELL | 2019-03-07 | 2019-03-11 | $83.57 | $33K | +0.9% | +1.6% | +23.0% |
| HAE | SELL | 2018-06-07 | 2018-06-08 | $92.73 | $42K | -2.4% | -1.4% | +18.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.